NICE green light for Roche's Rozlytrek
The drug targets all solid tumours with the NTRK gene fusions
25th June 2020
Latest news
Tech talent drawn to pharma during COVID-19 pandemic
83% of tech professionals would consider working in healthcare and pharma, with 72% more likely to consider it compared to six months ago, shows new research by Novartis
24th June 2020
New £1.3m national research programme to evaluate coronavirus tests
The multicentre programme will evaluate new tests in hospitals, GP surgeries and care homes around the country
24th June 2020
UK Home Office loosens restrictions on GW's Epidyolex
The cannabinoid has been reclassified as a Schedule 5 medicine meaning that it can be dispensed more easily
24th June 2020
Epidarex Capital closes life sciences venture fund at £102m
New UK fund underpinned by £50 million investment from the British Business Bank, via its Enterprise Capital Funds (ECF) programme
24th June 2020
Research charities warn of funding cuts in coronavirus wake
The Association of Medical Research Charities and 151 of its members are calling on the UK government to match charity funded research for the next three years
24th June 2020
Sanofi pays $300m upfront to expand deal with Translate Bio
The firms are working on the development of mRNA vaccines
23rd June 2020
Boehringer to sell stake in Hikma
Boehringer's stake in the firm equates to around 16.4%
23rd June 2020
New coronavirus saliva test to be trialled in Southampton
Over 14,000 GP staff, other essential key workers and university staff and their households will participate in the first phase of the trial
23rd June 2020
MHRA extends access to Santhera's DMD drug via the EAMS
The scientific opinion has been extended for one year while the drug is under regulatory review
23rd June 2020
Gilead to start testing an inhaled form of remdesivir
The firm is targeting an earlier stage in the treatment pathway for COVID-19
23rd June 2020
Last chance to register for the Patient Partnership Index 2020
Registration will close June 23 but entry forms can be submitted until July 3
22nd June 2020
GSK/Clover's COVID-19 vaccine moves into human trials
The Phase I study is assessing use of a GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019
22nd June 2020
Novartis pulls plug on hydroxychloroquine trial
Study assessing its potential for COVID-19 discontinued due to feasibility of recruitment
22nd June 2020
ABPI consults on 'new-look' Code of Practice
A new version of the Code is expected to come into force in July 2021
22nd June 2020
